Peptide Comparison Tool¶
Compare multiple peptides side-by-side across key parameters — class, sequence length, molecular weight, mechanism, and research applications. Request COA and product specification sheets for compared peptides.
Compare Peptides¶
How to Use This Comparison for Research Decisions¶
When selecting a peptide for research, the comparison matrix above provides a structured way to evaluate candidates across multiple dimensions. Here's how to use it effectively:
1. Compare by Core Parameters¶
Start by reviewing class, sequence length, molecular weight, and mechanism of action for each peptide. These parameters define the fundamental characteristics of each compound and determine its suitability for specific research applications.
- Class tells you the peptide's functional category (e.g., GLP-1 agonist, tissue repair, neuropeptide) — peptides within the same class often share overlapping mechanisms
- Length and MW affect stability, solubility, and administration considerations in research protocols
- Mechanism of action is the most critical differentiator — two peptides targeting the same general area may work through entirely different pathways
2. Understand Key Category Differences¶
GLP-1 Agonists — Tirzepatide vs. Semaglutide vs. Retatrutide
These three metabolic peptides illustrate how subtle receptor-targeting differences can lead to distinct research applications:
| Peptide | Receptor Target | Research Application |
|---|---|---|
| Tirzepatide | GIP + GLP-1 (dual agonist) | Dual pathway metabolic research, comparative efficacy studies |
| Semaglutide | GLP-1 (selective agonist) | Selective GLP-1 receptor studies, monotherapy models |
| Retatrutide | GIP + GLP-1 + Glucagon (triple agonist) | Triple agonism research, multi-receptor crosstalk studies |
Tirzepatide's dual agonism activates both GIP and GLP-1 receptors, offering broader metabolic pathway research. Semaglutide's selective GLP-1 agonism provides a focused tool for studying GLP-1-specific effects. Retatrutide's triple agonism adds glucagon receptor activation, enabling research into combined energy expenditure and glycemic control pathways.
Tissue Repair — BPC-157 vs. TB-500
These two popular regenerative peptides work through fundamentally different mechanisms:
- BPC-157 promotes angiogenesis (formation of new blood vessels) and systemic tissue protection, supporting recovery through improved blood supply to damaged tissues
- TB-500 (Thymosin β4 fragment) binds actin and promotes cell migration, supporting tissue regeneration through cytoskeletal remodeling and cell motility
Using these peptides in combination for research can explore synergistic mechanisms — angiogenesis from BPC-157 paired with actin-binding cell migration from TB-500 addresses tissue repair through complementary pathways.
3. Apply Comparisons to Purchasing Decisions¶
The comparison matrix directly links to product pages and COA requests. After evaluating peptides side-by-side:
- Use the product links in the comparison table to navigate directly to detailed specification sheets
- Click Request COA to obtain Certificate of Analysis documentation for the peptides you've compared
- Cross-reference molecular weight, sequence, and purity data against your research protocol requirements
Peptide Selection Guide¶
Use this quick-reference table to identify the best peptide for your specific research objective:
| Research Goal | Recommended Peptide(s) | Reason |
|---|---|---|
| Metabolic / Weight Loss Research | Tirzepatide or Semaglutide | GLP-1 receptor agonism for metabolic pathway studies |
| Triple Agonism Research | Retatrutide | GIP + GLP-1 + glucagon triple receptor activation |
| Soft Tissue Recovery Research | BPC-157 + TB-500 | Synergistic angiogenesis + actin-binding mechanisms |
| Dermal / Anti-Aging Research | GHK-Cu | Copper-dependent collagen synthesis and matrikine signaling |
| Cognitive Enhancement Research | Semax | BDNF and NGF modulation for neuroprotection studies |
| Sleep / Pineal Function Research | Epitalon | Telomerase regulation and circadian rhythm modulation |
| GH Secretagogue Research | MK-677 or Ipamorelin | GHS receptor agonism for growth hormone pathway studies |
This guide maps research goals to specific peptides, but always verify detailed specifications — including purity, sequence confirmation, and stability data — via the product pages and COA documentation.
Frequently Asked Questions¶
Start by identifying your research goal (e.g., metabolic studies, tissue repair, cognitive function). Use the Peptide Selection Guide above to match your goal to a recommended peptide. Then use the comparison tool to evaluate 2–4 candidates side-by-side by class, mechanism, molecular weight, and research applications. Finally, review the detailed technical profiles at data.rplpeptides.com and request a Certificate of Analysis to verify purity and specifications.
GLP-1 agonists differ primarily in their receptor selectivity profile. Semaglutide is a selective GLP-1 receptor agonist, targeting only the GLP-1 pathway. Tirzepatide is a dual agonist (GIP + GLP-1), activating two receptor systems simultaneously. Retatrutide is a triple agonist (GIP + GLP-1 + glucagon), adding glucagon receptor activation for broader metabolic research. The choice depends on whether your research requires single-pathway selectivity, dual-pathway comparison, or multi-receptor crosstalk analysis.
Yes — the comparison tool is designed to work across categories. You can select peptides from any combination of classes (e.g., a GLP-1 agonist alongside a tissue repair peptide). The matrix will display all key parameters side-by-side, allowing you to evaluate class, mechanism, and structural differences even across unrelated peptide families. This is useful for broad surveying or when designing multi-compound research protocols.
After selecting the peptides you'd like to compare, click the "Request COA →" button displayed in the comparison results. This will take you to the COA request form at rplpeptides.com/coa-request/ with the first compared peptide pre-selected. You can request COAs for any or all of the compared peptides from the form. Certificates include verified purity, sequence confirmation, and analytical data.
Visit data.rplpeptides.com for comprehensive technical profiles on each peptide, including detailed sequence information, structural data, stability studies, and research references. Product-specific specification sheets are also available from each product page at rplpeptides.com.
From Comparison to Purchase¶
The comparison matrix is more than a research tool — it's your bridge from product specifications to purchasing decisions.
How to Take the Next Steps¶
- Compare your candidates using the interactive tool above to evaluate class, mechanism, molecular weight, and applications side-by-side
- Visit data.rplpeptides.com for full technical profiles — each peptide's detailed characterization including sequence confirmation, analytical data, and research references
- Request a Certificate of Analysis from rplpeptides.com/coa-request/ to verify purity and specifications before purchase
- Browse and order from the complete product catalog — each product page links back to the corresponding comparison data
Why This Matters¶
The comparison tool links product specifications directly to research needs. Instead of jumping between datasheets, you can evaluate multiple candidates in a single view, match parameters to your protocol requirements, and proceed directly to documentation or purchase — all from one interface.
Browse All Products at rplpeptides.com →
Peptide Reference Data¶
| Peptide | Class | Length | MW (Da) | Sequence (1-letter) |
|---|---|---|---|---|
| Tirzepatide | GIP/GLP-1 Dual Agonist | 39 | 4,813.5 | YXGEGTFTSDYSILDSKKQRAKQFVQWLLAGGPSSGAPPPS |
| Semaglutide | GLP-1 Agonist | 31 | 4,113.6 | HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG |
| Retatrutide | Triple GIP/GLP-1/GCG | 39 | 4,840.6 | YXGEGTFTSDYSILDSKKQRAKQFVQWLLAGGPSSGAPPPS |
| BPC-157 | Tissue Repair | 15 | 1,419.5 | GEPPPGKPADDAGLV |
| TB-500 | Regenerative | 5 | 500.5 | Ac-SDKP |
| GHK-Cu | Cosmetic | 3 | 466.4 (complex) | GHK |
| Semax | Neuropeptide | 7 | 706.8 | MEHFPGP |
| Epitalon | Pineal Regulator | 4 | 375.4 | AEDG |
| MK-677 | GHS Agonist | N/A (small mol.) | 528.7 | N/A |
Using Comparison Results¶
The comparison tool helps you:
- Evaluate alternatives — Compare structural and functional differences between peptide candidates
- Inform purchasing decisions — Side-by-side parameter comparison for procurement
- Cross-reference with data.rplpeptides.com — Detailed technical profiles for each compound
- Request documentation — Direct CTA to COA requests and product specifications
Related Tools¶
- Molecular Weight Calculator — Calculate MW of custom sequences
- Peptide Properties Calculator — Detailed characterization
- Visit data.rplpeptides.com — Complete peptide database